Open-Label, Pharmacokinetic Study of the Penetration of Ceftobiprole Into Bone.
Phase of Trial: Phase I
Latest Information Update: 27 Jul 2012
At a glance
- Drugs Ceftobiprole medocaril (Primary)
- Indications Postoperative infections
- Focus Pharmacokinetics
- Sponsors Janssen Pharmaceuticals
- 27 Jul 2012 Actual initiation date changed from 1 May 2009 to 1 Apr 2009 as reported by ClinicalTrials.gov record.
- 27 Jul 2012 Company (Basilea Pharmaceutica) added as an association and lead centre as reported by ClinicalTrials.gov record.
- 31 Mar 2010 Actual patient number (22) added as reported by ClinicalTrials.gov.